3/23
09:14 am
nyxh
Nyxoah (NYXH) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Low
Report
Nyxoah (NYXH) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $11.00 price target on the stock.
3/21
08:11 am
nyxh
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 [Yahoo! Finance]
Low
Report
Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 [Yahoo! Finance]
3/20
05:30 pm
nyxh
Publication relating to transparency notifications
Low
Report
Publication relating to transparency notifications
3/20
12:21 pm
nyxh
Nyxoah (NYXH) had its price target lowered by Stifel Nicolaus from $11.00 to $10.00. They now have a "buy" rating on the stock.
Low
Report
Nyxoah (NYXH) had its price target lowered by Stifel Nicolaus from $11.00 to $10.00. They now have a "buy" rating on the stock.
3/20
01:17 am
nyxh
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges [Yahoo! Finance]
Low
Report
Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges [Yahoo! Finance]
3/19
06:03 pm
nyxh
Nyxoah Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Nyxoah Q4 Earnings Call Highlights [Yahoo! Finance]
3/19
04:10 pm
nyxh
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Low
Report
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
3/13
05:30 pm
nyxh
Publication relating to transparency notification
Low
Report
Publication relating to transparency notification
3/11
05:05 pm
nyxh
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Medium
Report
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
3/5
04:05 pm
nyxh
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Low
Report
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
3/5
07:56 am
nyxh
Nyxoah (NYXH) was upgraded by Cantor Fitzgerald to "strong-buy".
Medium
Report
Nyxoah (NYXH) was upgraded by Cantor Fitzgerald to "strong-buy".
2/27
04:30 pm
nyxh
Publication relating to transparency notifications
Low
Report
Publication relating to transparency notifications
2/25
04:30 pm
nyxh
Information on the total number of voting rights and shares
Medium
Report
Information on the total number of voting rights and shares
2/18
04:05 pm
nyxh
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
Medium
Report
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
1/29
10:58 am
nyxh
Nyxoah (NASDAQ:NYXH) was given a new $11.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Low
Report
Nyxoah (NASDAQ:NYXH) was given a new $11.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
1/21
04:05 pm
nyxh
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
Low
Report
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
1/12
04:05 pm
nyxh
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
Low
Report
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
1/12
01:00 am
nyxh
Publication relating to transparency notification
Low
Report
Publication relating to transparency notification